Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

4 results

  1. SOCIAL QUESTIONS|health|pharmaceutical industry
    substaint ghníomhach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'EUR 145200 i gcás ina n-áirítear trí shubstaint ghníomhacha agus/nó trí theaglaim de shubstaintí gníomhacha sa mheasúnú...' Reference "Rialachán (AE) Uimh. 658/2014 maidir le táillí is iníoctha leis an nGníomhaireacht Leigheasra Eorpach chun gníomhaíochtaí cógas-aireachais a dhéanamh i ndáil le táirgí íocshláinte lena n-úsáid ag an duine, CELEX:32014R0658/GA"
    substaint atá gníomhach ó thaobh na cógaseolaíochta de Reference "Rialachán (CE) Uimh. 470/2009 lena leagtar síos nósanna imeachta Comhphobail chun teorainneacha na n-iarmhar a bhunú do shubstaintí atá gníomhach ó thaobh na cógaseolaíochta de i mbia-ábhair de thionscnamh ainmhíoch, CELEX:32009R0470/GA"
    ga
    Wirkstoff | wirksamer Bestandteil | arzneilich wirksamer Bestandteil | pharmakologisch wirksamer Stoff | Arzneistoff
    de
    Definition Stoff, der bei der Herstellung eines Arzneimittels zu einem seiner pharmakologisch wirksamen Bestandteile wird Reference "Council-DE, vgl. Verordnung (EU) 2019/6 über Tierarzneimittel, Art. 4 Abs. 3"
    Comment """Anders formuliert sind Wirkstoffe also diejenigen Bestandteile eines Arzneimittels, die für seine Wirksamkeit verantwortlich sind."""
    active substance | pharmacologically active substance | active ingredient | therapeutic entity | therapeutic substance
    en
    Definition substance responsible for the pharmacological activity of a medicinal product Reference "COM-Terminology Coordination, based on: 'active substance' (26.7.2023). EMA. Glossary"
    Comment "The quantity of the active substance should be expressed per dosage unit (for metered dose inhalation products, per delivered dose and/or per metered dose), per unit volume, or per unit of weight and should be related to the declaration of strength in section 1. Quantity should be expressed in internationally recognised standard term which could be complemented with another term if more meaningful to healthcare professionals."
    substance active
    fr
  2. INTERNATIONAL RELATIONS|international affairs|international agreement · SOCIAL QUESTIONS|health|health policy · INTERNATIONAL RELATIONS|international affairs|international instrument|international convention|European convention · INTERNATIONAL ORGANISATIONS|European organisations|European organisation|Council of Europe
    Prótacal breise a ghabhann leis an gComhaontú Eorpach maidir le Malartú Substaintí Teirpeacha de Bhunús Daonna Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Zusatzprotokoll zu dem Europäischen Übereinkommen über den Austausch therapeutischer Substanzen menschlichen Ursprungs
    de
    Comment Strassburg, 01.01.1983
    Additional Protocol to the European Agreement on the Exchange of Therapeutic Substances of Human Origin
    en
    Comment "Signed: Strasbourg, 1.1.1983Entry into force: 1.1.1985European Treaty Series (ETS) No. 109Authentic versions: EN-FRSince its entry into force, this Protocol forms an integral part of Agreement ETS 026 ( IATE:769182 )"
    Protocole additionnel à l'Accord européen relatif à l'échange de substances thérapeutiques d'origine humaine
    fr
    Definition "protocole additionnel permettant à l'Union européenne de devenir Partie à l'Accord IATE:769182 par signature de celui-ci" Reference "site Council of Europe, résumé du traité, http://conventions.coe.int/Treaty/fr/Summaries/Html/026.htm (28.3.2012)"
    Comment Signature: 1.1.1983 à StrasbourgEntrée en vigueur:1.1.1985Conseil de l'Europe; STCE n° 109Versions authentiques: EN-FR
  3. INTERNATIONAL RELATIONS|international affairs|international agreement · SOCIAL QUESTIONS|health|health policy · INTERNATIONAL RELATIONS|international affairs|international instrument|international convention|European convention · INTERNATIONAL ORGANISATIONS|European organisations|European organisation|Council of Europe
    an Comhaontú Eorpach maidir le Malartú Substaintí Teirpeacha de Bhunús Daonna Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Europäisches Übereinkommen über den Austausch therapeutischer Substanzen menschlichen Ursprungs
    de
    Comment Paris, 15.12.1958
    European Agreement on the Exchange of Therapeutic Substances of Human Origin
    en
    Definition agreement aiming to ensure mutual assistance between parties in the supply of therapeutic substances of human origin should the need arise. Reference "Council-EN, based on Council of Europe Treaty Office summary (Treaty No. 026) (25.2.2020)"
    Comment "Signed: Paris, 15.12.1958Entry into force: 1.1.1959European Treaty Series (ETS) No. 026Additional Protocol ETS No. 109 ( IATE:775461 ) provides for the accession of the European Economic Community to the Agreement by signing it and since its entry into force forms an integral part of this Agreement."
    Accord européen relatif à l'échange de substances thérapeutiques d'origine humaine
    fr
    Definition accord dont l'objectif est d'apporter une assistance mutuelle en vue de la fourniture des substances thérapeutiques d'origine humaine Reference "site Conseil de l'Europe, résumé du traité, http://conventions.coe.int/Treaty/fr/Summaries/Html/026.htm (22.3.2012)"
    Comment Signature: 15.12.1958 à ParisEntrée en vigueur: 1.1.1959Conseil de l'Europe; STCE n° 026Versions authentiques: EN-FR
  4. SOCIAL QUESTIONS|health|pharmaceutical industry · SOCIAL QUESTIONS|health|medical science|therapeutics
    substaint theiripeach de bhunús daonna Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Substaintí teiripeacha de bhunús daonna agus imoibrithe ghrúpála fola agus tíopála fíocháin...' Reference "Rialachán Cur Chun Feidhme (AE) 2021/235 lena leasaítear Rialachán Cur Chun Feidhme (AE) 2015/2447 maidir le formáidí agus cóid na gcomhcheanglas sonraí, rialacha áirithe i dtaca le faireachas agus leis an oifig inniúil custaim lena gcuirtear earraí faoi nós imeachta custaim,CELEX:32021R0235/GA"
    therapeutic substance of human origin
    en
    Definition human blood and its derivatives Reference "Directive 2009/132/EC determining the scope of Article 143(b) and (c) of Directive 2006/112/EC as regards exemption from value added tax on the final importation of certain goods (codified version)"